Clinical Trial Update: Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating carbon ion radiotherapy for resectable or borderline resectable pancreatic cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Snippet

Sponsor: CNAO National Center of Oncological Hadrontherapy | Conditions: Cancer of Pancreas, Pancreas Adenocarcinoma | Phase 2 | Status: TERMINATED